Hadas Bar-Joseph Selected Research

Hyperplasia

12/2015

Pigment Epithelium-Derived Factor Alleviates Tamoxifen-Induced Endometrial Hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hadas Bar-Joseph Research Topics

Disease

4	Neoplasms (Cancer) 05/2020 - 10/2014
2	Breast Neoplasms (Breast Cancer) 05/2020 - 12/2015
1	Vascular System Injuries 01/2021
1	Leiomyoma (Uterine Fibroids) 08/2020
1	Pre-Eclampsia (Preeclampsia) 05/2020
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 05/2020
1	Retinal Degeneration 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Hyperandrogenism 01/2020
1	Ovarian Hyperstimulation Syndrome 02/2016
1	Endometrial Hyperplasia 12/2015
1	Hyperplasia 12/2015
1	Cardiotoxicity 01/2015

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2020
2	pigment epithelium-derived factorIBA 08/2020 - 12/2015
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021
1	CeramidesIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	AcidsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 08/2020
1	AnthracyclinesIBA 05/2020
1	Epirubicin (Ellence)FDA LinkGeneric 05/2020
1	CytokinesIBA 01/2020
1	Cyclin AIBA 01/2020
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 02/2016
1	Hormones (Hormone)IBA 12/2015
1	Tamoxifen FDA LinkGeneric 12/2015

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
2	Therapeutics 12/2015 - 01/2015